
Abivax SA American Depositary Shares – NASDAQ:ABVX
Abivax SA American Depositary Shares stock price today
Abivax SA American Depositary Shares stock price monthly change
Abivax SA American Depositary Shares stock price quarterly change
Abivax SA American Depositary Shares stock price yearly change
Abivax SA American Depositary Shares key metrics
Market Cap | 478.18M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | -7 |
Revenue | N/A |
EBITDA | -187.86M |
Income | -217.58M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAbivax SA American Depositary Shares stock price history
Abivax SA American Depositary Shares stock forecast
Abivax SA American Depositary Shares financial statements
Jun 2022 | 0 | -29.55M | |
---|---|---|---|
Dec 2022 | 0 | -40.29M | |
Jun 2023 | 0 | -51.95M | |
Dec 2023 | 0 | -95.78M |
2025 | 3.04M | -112.98M | -3705.73% |
---|---|---|---|
2026 | 4.49M | -110.91M | -2465.67% |
2027 | 76.75M | -104.19M | -135.75% |
2028 | 267.88M | -43.29M | -16.16% |
Analysts Price target
Financials & Ratios estimates
Jun 2022 | 71642000 | 65.56M | 91.51% |
---|---|---|---|
Dec 2022 | 73352000 | 64.65M | 88.14% |
Jun 2023 | 171081000 | 90.59M | 52.95% |
Dec 2023 | 327062000 | 131.05M | 40.07% |
Jun 2022 | -25.75M | -3.77M | -4.60M |
---|---|---|---|
Dec 2022 | -39.82M | 44K | 40.15M |
Jun 2023 | -28.84M | -1.71M | 117.99M |
Dec 2023 | -71.16M | -8.78M | 222.57M |
Abivax SA American Depositary Shares alternative data
Nov 2023 | 26 |
---|---|
Dec 2023 | 26 |
Jan 2024 | 26 |
Feb 2024 | 26 |
Mar 2024 | 26 |
Apr 2024 | 26 |
May 2024 | 61 |
Jun 2024 | 61 |
Jul 2024 | 61 |
Abivax SA American Depositary Shares other data
-
What's the price of Abivax SA American Depositary Shares stock today?
One share of Abivax SA American Depositary Shares stock can currently be purchased for approximately $69.65.
-
When is Abivax SA American Depositary Shares's next earnings date?
Unfortunately, Abivax SA American Depositary Shares's (ABVX) next earnings date is currently unknown.
-
Does Abivax SA American Depositary Shares pay dividends?
No, Abivax SA American Depositary Shares does not pay dividends.
-
How much money does Abivax SA American Depositary Shares make?
Abivax SA American Depositary Shares has a market capitalization of 478.18M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 0.83% to 4.62M US dollars.
-
What is Abivax SA American Depositary Shares's stock symbol?
Abivax SA American Depositary Shares is traded on the NASDAQ under the ticker symbol "ABVX".
-
What is Abivax SA American Depositary Shares's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Abivax SA American Depositary Shares?
Shares of Abivax SA American Depositary Shares can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Abivax SA American Depositary Shares have?
As Jul 2024, Abivax SA American Depositary Shares employs 61 workers, which is 135% more then previous quarter.
-
When Abivax SA American Depositary Shares went public?
Abivax SA American Depositary Shares is publicly traded company for just a year since IPO on 20 Oct 2023.
-
What is Abivax SA American Depositary Shares's official website?
The official website for Abivax SA American Depositary Shares is abivax.com.
-
How can i contact Abivax SA American Depositary Shares?
Abivax SA American Depositary Shares can be reached via phone at +33 1 53 83 09 63.
Abivax SA American Depositary Shares company profile:

Abivax SA American Depositary Shares
abivax.comNASDAQ
62
Biotechnology
Healthcare
ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of moderately to severely active ulcerative colitis. ABIVAX Société Anonyme was incorporated in 2013 and is headquartered in Paris, France.
Paris, 75009
CIK: 0001956827
ISIN: US00370M1036
: